Cargando…

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma

OBJECTIVE: Metabolic alteration is widely considered as one of the hallmarks of cancer. Hepatocellular carcinoma (HCC) presents a unique pathological feature in which lipid accumulation is common in well-differentiated HCC and rare in poorly differentiated HCC; however, the underlying mechanism rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Hideo, Kohjima, Motoyuki, Tanaka, Masatake, Goya, Takeshi, Itoh, Shinji, Yoshizumi, Tomoharu, Mori, Masaki, Tsuda, Mariko, Takahashi, Motoi, Kurokawa, Miho, Imoto, Koji, Tashiro, Shigeki, Kuwano, Akifumi, Kato, Masaki, Okada, Seiji, Nakamuta, Makoto, Ogawa, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910064/ https://www.ncbi.nlm.nih.gov/pubmed/33681091 http://dx.doi.org/10.1155/2021/8813410

Ejemplares similares

Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients
por: Kuwano, Akifumi, et al.
Publicado: (2021)

Microcirculatory disturbance in acute liver injury
por: Kuwano, Akifumi, et al.
Publicado: (2021)

Clinical Features of Liver Injury Induced by Immune Checkpoint Inhibitors in Japanese Patients
por: Imoto, Koji, et al.
Publicado: (2019)

Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
por: Imoto, Koji, et al.
Publicado: (2022)

Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failure
por: Kuwano, Akifumi, et al.
Publicado: (2023)

Acute kidney injury is an unfavorable prognostic factor in acute liver failure and is associated with tumor necrosis factor-alpha
por: Imoto, Koji, et al.
Publicado: (2023)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
por: Sugimoto, Rie, et al.
Publicado: (2022)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
por: Kotoh, Kazuhiro, et al.
Publicado: (2009)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis
por: Okabe, Hirohisa, et al.
Publicado: (2016)

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study
por: Kotoh, Kazuhiro, et al.
Publicado: (2008)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments
por: Yamashita, Yo‐ichi, et al.
Publicado: (2018)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
por: Kohjima, Motoyuki, et al.
Publicado: (2007)

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
por: Nakano, Masahito, et al.
Publicado: (2022)

Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report
por: Shiraishi, Jin, et al.
Publicado: (2023)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma
por: Kaibori, Masaki, et al.
Publicado: (2016)

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
por: Sugimoto, Rie, et al.
Publicado: (2022)

Spontaneous Massive Necrosis of Hepatocellular Carcinoma with Narrowing and Occlusion of the Arteries and Portal Veins
por: Tomino, Takahiro, et al.
Publicado: (2014)

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
por: Enjoji, Munechika, et al.
Publicado: (2010)

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
por: Enjoji, Munechika, et al.
Publicado: (2012)

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments
por: Enjoji, Munechika, et al.
Publicado: (2012)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach
por: Watanabe, Hirofumi, et al.
Publicado: (2018)

Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin
por: Kurokawa, Tomoharu, et al.
Publicado: (2016)

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
por: Itoh, S., et al.
Publicado: (2019)

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice
por: Motomura, Kenta, et al.
Publicado: (2023)

The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
por: Meguro, Makoto, et al.
Publicado: (2011)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aoq5g7kr8vnhaq6q8dbmpak5iu